from Reuters: Top News https://ift.tt/2ICTgHV Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
Roche bets $4.3 billion on Spark in gene therapy move
Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.

from Reuters: Top News https://ift.tt/2ICTgHV Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
from Reuters: Top News https://ift.tt/2ICTgHV Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.
Related Posts:
U.S. tightens Venezuela oil sanctions, indicates more actions to comeThe U.S. Treasury Department on Thursday tightened its pressure on Venezuela's state-owned oil company by making clear that exports of diluents by int… Read More
Pentagon Ends Review of Deadly Niger Ambush, Again Blaming Junior OfficersMilitary leaders have struggled over how to apportion blame over the deaths of four American soldiers amid family members’ demands to hold more senior… Read More
Your Thursday BriefingPresident Trump, D-Day, Fiat-Renault: Here’s what you need to know. from NYT > World https://nyti.ms/2KtGN8U … Read More
Peru president vows to keep deporting Venezuelans with criminal recordsPeru's president on Thursday vowed to continue deporting Venezuelans with criminal records as long as necessary, part of a tougher stance toward Venez… Read More
Asia shares muted, trade risk offsets rate hopesAsian markets were in a mixed mood on Thursday as fears the U.S. trade tussle with Mexico would further depress global growth, warred with wagers cent… Read More
0 comments:
Post a Comment